Search Results 141-150 of 19712 for Receptor

  1. Hormone Therapy For Breast Cancer Clinical Trials - Mayo Clinic Research

    ... receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and ...

  2. CAR-T Cell Therapy Program - Clinical trials

    The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...

  3. Invasive lobular carcinoma - Diagnosis and treatment - Mayo Clinic

    Special tests give more details about the cancer cells. For example, tests might look for hormone receptors on the surface of the cells. Your healthcare team ...

  4. Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T) - Mayo Clinic

    Treating Highly Sensitized Patients on the Kidney Transplant Waiting List by Depleting Their B-cells Using Chimeric Antigen Receptor T Cells (CAR-T) · Overview.

  5. Thomas C. Spelsberg, Ph.D. - Mayo Clinic Faculty Profiles

    D., is engaged in studies regarding the mechanism of action of estrogens, selective estrogen receptor modulators (SERMs), select growth factors, and ...

  6. Clinical trials - Oncology (Medical)

    ... receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer that has progressed on treatment with ...

  7. How are Helper T-Cells Made? And Yes, It's Important.

    T-cells have a port, or receptor, that matches to an antigen. When that happens, the T-cell turns into either a chemical weapon or an alarm bell. Both are ...

  8. Genetic Analysis in Blood and Tumor Samples From Patients With Advanced or Metastatic Estrogen Receptor Positive and HER2 Negative Breast Cancer Receiving Palbociclib and Endocrine Therapy - Mayo Clinic

    This research trial studies genetic profiles in blood and tumor samples from patients with estrogen receptor positive and HER2 negative breast cancer that has ...

  9. Publications - Andrew C. Greenlund, M.D., Ph.D. - Mayo Clinic

    Greenlund AC, Morales MO, Viviano BL, Yan H, Krolewski J, Schreiber RD. STAT recruitment by tyrosin phosphorylated cytokine receptors: an ordered reversible ...

  10. Datopotamab deruxtecan-dlnk (intravenous route) - Side effects & uses - Mayo Clinic

    Datopotamab deruxtecan-dlnk injection is also used to treat hormone receptor (HR)-positive, human epidermal growth factor receptor 2 HER2-negative (IHC 0 ...